Cargando…
Bortezomib Reduces Neointimal Hyperplasia in a Rat Carotid Artery Injury Model
BACKGROUND AND OBJECTIVES: The ubiquitin-proteasome system is the major intracellular protein degradation pathway in the eukaryotic cells. Bortezomib inhibits 26S proteasome-induced I-κBα degradation and suppresses nuclear factor-kappa B (NF-κB) activation. We examined the effect of bortezomib on ne...
Autores principales: | Kim, Ki-Seok, Kim, Song Yi, Choi, Joon Hyeok, Joo, Seung Jae, Kim, Dong Woon, Cho, Myeong Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808854/ https://www.ncbi.nlm.nih.gov/pubmed/24174959 http://dx.doi.org/10.4070/kcj.2013.43.9.592 |
Ejemplares similares
-
Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice
por: Kim, Jong-Ho, et al.
Publicado: (2019) -
Effects of Combination Therapy with Celecoxib and Doxycycline on Neointimal Hyperplasia and Inflammatory Biomarkers in Coronary Artery Disease Patients Treated with Bare Metal Stents
por: Kim, Won Ho, et al.
Publicado: (2012) -
A novel CD147 inhibitor, SP-8356, reduces neointimal hyperplasia and arterial stiffness in a rat model of partial carotid artery ligation
por: Pahk, Kisoo, et al.
Publicado: (2019) -
Enhanced neointimal hyperplasia and carotid artery remodelling in sequestosome 1 deficient mice
por: Sugimoto, Rika, et al.
Publicado: (2010) -
Inhibition of neointimal proliferation of rat carotid artery by sulodexide.
por: Park, H. Y., et al.
Publicado: (1997)